LawPlayer
My bookmarks
Source

Commission Implementing Regulation (EU) 2017/2327 of 14 December 2017 approving 2-methyl-1,2-benzisothiazol-3(2H)-one as an active substance for use in biocidal products of product-type 6 (Text with EEA relevance. )

Commission Implementing Regulation (EU) 2017/2327 of 14 December 2017 approving 2-methyl-1,2-benzisothiazol-3(2H)-one as an active substance for use in biocidal products of product-type 6 (Text with EEA relevance. )

Implementing Regulation (EU) 2017/2327 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

2-methyl-1,2-benzisothiazol-3(2H)-one is approved as an active substance for use in biocidal products of product-type 6, subject to the specifications and conditions set out in the Annex.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance  ( 1 ) Date of approval Expiry date of approval Product type Specific conditions 2-methyl-1,2-benzisothiazol-3(2H)-one (MBIT) IUPAC Name: 2-methyl-1,2-benzisothiazol-3(2H)-one EC No: Not available CAS No: 2527-66-4 ≥ 997 g/kg 1 July 2018 30 June 2028 6 The authorisations of biocidal products are subject to the following conditions: (1) the product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance; (2) in view of the risks identified for the uses assessed, the product assessment shall pay particular attention to: (a) professional users; (b) surface water and groundwater for the outdoor use of preserved paints and plasters and the use of preserved fluids used in paper, textile or leather production. The placing on the market of treated articles is subject to the following condition: The person responsible for the placing on the market of a treated article treated with or incorporating 2-methyl-1,2-benzisothiazol-3(2H)-one shall ensure that the label of that treated article provides the information listed in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012. ( 1 )   The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.

Other acts of the same type
Commission Implementing Regulation (EU) 2026/1893 of 30 July 2026 suspending commercial rebalancing measures concerning certain products originating in the United States of America and certain products exported from the Union to the United States of America imposed by Implementing Regulation (EU) 2025/1564Council Implementing Regulation (EU) 2026/1895 of 30 July 2026 implementing Regulation (EU) 2020/1998 concerning restrictive measures against serious human rights violations and abusesCommission Implementing Regulation (EU) 2026/1908 of 30 July 2026 amending Annex I to Implementing Regulation (EU) 2023/594 laying down special disease control measures for African swine feverCommission Regulation (EU) 2026/1825 of 29 July 2026 amending Regulation (EU) 2023/915 as regards maximum levels of 3-monochloropropanediol (3-MCPD), 3-MCPD fatty acid esters and glycidyl fatty acid esters in certain foodsCommission Implementing Regulation (EU) 2026/1859 of 29 July 2026 concerning the renewal of the authorisation of a preparation of taurine as a feed additive for Canidae, Felidae, Mustelidae, carnivorous finfish and other aquatic carnivorous species and repealing Implementing Regulation (EU) 2015/722Commission Implementing Regulation (EU) 2026/1860 of 29 July 2026 concerning the authorisation of a preparation of narasin (Monteban G100) as a feed additive for chickens for fattening (holder of authorisation: Elanco GmbH) and repealing Regulation (EC) No 1464/2004Commission Implementing Regulation (EU) 2026/1864 of 29 July 2026 specifying the technical items of the data set, establishing the technical formats for transmission of information and specifying the arrangements and content of the quality reports on the organisation of a sample survey in the use of information and communication technologies domain for reference year 2027 pursuant to Regulation (EU) 2019/1700 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2026/1865 of 29 July 2026 concerning the authorisation of thyme essential oil from Thymus vulgaris L. and/or Thymus zygis L. as a feed additive for all animal speciesCommission Implementing Regulation (EU) 2026/1872 of 29 July 2026 amending the implementing technical standards laid down in Implementing Regulation (EU) 2016/2070 as regards benchmark portfolios, reporting templates and reporting instructions to be applied in the Union for the reporting referred to in Article 78(2) of Directive 2013/36 /EU of the European Parliament and of the CouncilCommission Regulation (EU) 2026/1890 of 29 July 2026 amending Regulation (EU) 2023/915 as regards maximum levels of the sum of furan, 2-methylfuran and 3-methylfuran in processed cereal-based food for infants and young children and in baby foodCommission Implementing Regulation (EU) 2026/1824 of 28 July 2026 making imports of lysine originating in the People’s Republic of China subject to registration with a view to allowing the levy of anti-dumping duties on the imports subject to registrationCommission Implementing Regulation (EU) 2026/1826 of 28 July 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, amisulbrom, Bacillus amyloliquefaciens strain MBI 600, beflubutamid, clomazone, cyantraniliprole, cyprodinil, daminozide, dichlorprop-P, dimethachlor, fludioxonil, formetanate, fosetyl, isofetamid, metalaxyl, metazachlor, penconazole, phenmedipham, pirimicarb, pyraclostrobin and S-abscisic acid

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next